SETMAR and cancer: In conclusion, based on the gnomAD and pLI, SETMAR does not seem to be an essential gene, i.e can tolerate mutations without displaying disease phenotypes, at least as heterozygous, but rather to be implicated or associated to cancers with changes in expression levels associated to alternative splicing.